RxDoctor Payments Data

Maria Martinez, NP

Family · American Fork, UTNPI 1932740651

Payments from drug & device makers

$4,438in general payments, 2019–2025

Across 229 payments — averaging $19.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$787
  • AstraZeneca$692
  • Amgen$583
  • Bayer$515
  • Travere Therapeutics, Inc.$383
  • Vifor Pharma, Inc.$307
  • plus $1K from 18 others

What the payments were for

  • Food & beverage$4,424100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,438 in reported general payments places this provider in the 90th percentile of 1,460 family providers in Utah.

See all family providers in Utah

Medicare billing

Part B allowed, 2024
$67,949
Medicare patients
247
Services billed
1,233

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LokelmaSodium Zirconium Cyclosilicate19$20,986
KerendiaFinerenone11$9,255
Calcitriol98$945
Valsartan19$581
Bumetanide14$442
Torsemide20$429
Doxazosin Mesylate11$338
Amlodipine Besylate47$240
Carvedilol19$218
Furosemide29$212
Lisinopril24$191
Losartan Potassium16$185
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav13$129

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaLokelma$692$20,98619 claims
BayerKerendia$515$9,25511 claims
ANI Pharmaceuticals, Inc.Valsartan$107$58119 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,460 family providers in Utah.

Other family in American Fork

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →